Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely human insulin (as human insulin zinc suspension mixed) 1000 unit/10 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |
Product containing human insulin zinc suspension mixed in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |
Product containing human insulin zinc suspension mixed (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |
Product containing only human insulin zinc suspension mixed in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |
Product containing only human insulin zinc suspension mixed (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |
Product containing precisely human insulin (as human insulin zinc suspension mixed) 100 unit/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Human insulin zinc suspension mixed |
Inferred relationship |
Some |
1 |